Jeff E. Knight, Chief Operating Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 34,718 shares at $44.22 ($1.5M) on 2024-03-22, disclosed to the SEC on 2024-03-26.
Open-market sale of $1.5M CRNX by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.22 | 30,000 | $1.3M | 86.1% |
| 2 | $45.39 | 2,359 | $107K | 6.9% |
| 3 | $45.39 | 2,359 | $107K | 6.9% |
| Total | $44.38 avg | 34,718 | $1.5M | 100% |
| Filing → |
| CRNX | SELL | 2025-03-21 | $477K | — | Filing → |
| CRNX | SELL | 2024-11-26 | $28K | — | Filing → |
| CRNX | SELL | 2024-07-17 | $1.5M | — | Filing → |